The following is a list of the major categories of psychotropic drugs. Based on 2009 data, below is a list of the ten most prescribed psychotropic drugs in the United States. The number following ...

the main second-line diabetes medications—older drugs such as sulfonylureas (SUs) and dipeptidyl peptidase-4s (DPP-4s), and newer drugs including glucagon-like peptide-1 (GLP-1RAs) analogs and ...

It is self-evident that the longer a group is treated with a sulfonylurea drug, the greater the number of secondary failures that will accrue, although there is some disagreement over the nature ...

Parents pushed for years for treatments for the neuron disease Niemann-Pick type C. After setbacks, one drug now has FDA ...

Are you searching for medications to treat 'Diabetes'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Diabetes. The page includes both the ...

Medindia's A-Z index page eases your search for side effects of prescription and over-the-counter or OTC medications. Section deals with the comprehensive list of drugs approved by FDA.

And how much does it really cost to bring a drug to market? Increasingly, though, these debates are happening when everyone knows that the list price is not the ‘real’ price to be paid ...

Am J Health Syst Pharm. 2006;63(10):929-938. The goal of sulfonylurea overdose management is the return of euglycemia, with either dextrose supplementation or reduction of insulin secretion.

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

Sulfonylureas close these channels and restore insulin release, and have been successfully used to replace insulin treatment for patients with Kir6.2 mutations. Now, Hattersley et al. describe the ...

After many months of closely watched negotiations, the Centers for Medicare & Medicaid Services (CMS) announced the list of negotiated prices for 10 drugs. This marks the first set of negotiations ...

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...